Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

chemvet dk a/s - actinobacillus pleuropneumoniae serotype 2, strain app 2tr98, inactivated, actinobacillus pleurneumoniae serotype 9, strain app 9kl97, inactivated, apx i toxoid, apx ii toxoid, apx iii toxoid - emulsion for injection - 1-10 per cent - actinobacillus/haemophilus vaccine - porcine - immunological - inactivated vaccine

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

ceva santé animale - actinobacillus pleuropneumoniae strain nt3; actinobacillus pleurpneumoniae strain szii; actinobacillus pleuropneumoniae strain po; actinobacillus pleuropneumoniae strain u3; actinobacillus pleuropneumoniae strain b4 - suspension for injection - . - actinobacillus/haemophilus vaccine - pigs - immunological - inactivated vaccine

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

chemvet dk a/s - actinobacillus pleuropneumoniae serotype 2, strain app 2tr98, inactivated; apx i toxoid; apx ii toxoid; apx iii toxoid; actinobacillus pleuropneumoniae serotype 9, strain app 9kl97, inactivated - emulsion for injection - 1.0 - 10.0 unit(s) - actinobacillus/haemophilus vaccine - pigs - immunological - inactivated vaccine

Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

elanco philippines, inc.; distributor: elanco philippines, inc. - inactivated actinobacillus pleuropneumoniae , glaesserella parasuis , pasteurella multocida bacterin - solution for injection (im) - ormulation: each 2 ml contains: actinobacillus pleuropneumoniae, strain 80-1144 - gli (serotype 1) 21.27 od (600 nm) actinobacillus pleuropneumoniae, strain 81-1319 - gl4 (serotype 5) >i.26 od (600 nm) actinobacillus pleuropneumoniae, strain 5751-7 - gl34 (serotype 7) >i.37 od (600 nm) glaesserella parasuis >i.53 od (600 nm) pasteurella multocida serotype a, strain 169 26.3 x 10°cfu (0.28 ml)

Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: pasteurella multocida (type a)... ............ 8 x 10^9 actinobacillus pleuropneumoniae (serotype 2) ............ >1/4 mat titer actinobacillus pleuropneumoniae (serotype 4)............. >1/4 mat titer actinobacillus pleuropneumoniae (serotype 5) ............. > 1/4 mat titer mat - microagglutination test

Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

virbac philippines inc.; distributor: virbac philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , mycoplasma hyopneumoniae , streptococcus suis , haemophilus parasuis vaccine (vet.) - suspension for injection (im) - formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein

Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

virbac phillippines inc. - inactivated actinobacillus pleuropneumoniae , pasteurella multocida vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae type 1, 2 and 5 ....... >10^ 9.2 cfu before inactivation pasteurella multocida, type d (pm-18 strain) ......... >10^ 9.2 cfu before inactivation cfu - colony forming unit

Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

agrimate, inc.; distributor: agrimate, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae toxoid vaccine (vet.) - suspension for injection (im) - each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit

Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae, serovar 1,2,3,4,5 and 7......................> 107 cfu (before inactivation) cfu - colony forming unit

Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

superiorvet inc.; distributor: superiorvet inc. - inactivated actinobacillus pleuropneumoniae , mesomycoplasma hyopneumoniae vaccine (vet.) - vaccine - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae, serotype 1 (41-1 strain) ............... 1-5 x 109 cells serotype 2 (shp-1 strain) ............... 1-5 x 10° cells serotype 5 (ng-2 strain) ............... 1-5 x 10° cells actinobacillus pleuropneumoniae cytotoxin rapx i, ii, iii protein ....... 80-120 ug (recombinant a. pleuropneumoniae produced in escherichia coli) mesomycoplasma hyopneumoniae (mi-3 strain) .......... ........ 21 x 108 cells